未登录

J

Jene Choi

Asan Medical Center

H指数:19

被引数:1,307

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular and clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1

ROS1融合变体的分子和临床特征：ROS1重排癌中融合伴侣和断点的明确作用

European Journal of Cancer

IF7.1

2025-11-020

PRE

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer

CELL DEATH & DISEASE

IF9.6

2024-12-180

OAAI

Concordances assessment between MET-positive circulating tumour cells and disease progression in patients with EGFR mutated NSCLC

MET阳性循环肿瘤细胞与EGFR突变型NSCLC患者疾病进展之间的共现性评估

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2024-02-012

OAAI

Overexpression of the NEK9-EG5 axis is a novel metastatic marker in pathologic stage T3 colon cancer

SCIENTIFIC REPORTS

IF3.9

2023-01-079

OAAI

EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity

MOLECULAR CANCER RESEARCH

IF4.7

2022-02-2512

OA

Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation

IF6.2

2021-10-1836

OA

EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7

JOURNAL OF CELL SCIENCE

IF3.6

2020-05-1130

OA

Clinical Implications of the CMV-Specific T-Cell Response and Local or Systemic CMV Viral Replication in Patients With Moderate to Severe Ulcerative Colitis

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2019-12-183

OAAI

Therapeutic effect of mesenchymal stem cells derived from human umbilical cord in rabbit temporomandibular joint model of osteoarthritis

SCIENTIFIC REPORTS

IF3.9

2019-09-2544

OAAI

Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses

SCIENTIFIC REPORTS

IF3.9

2019-04-2934

OAAI

Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study

通过荧光原位杂交评估FGF19扩增的肝细胞癌患者的特征: 一项大型队列研究

IF9.1

2018-05-2228

OAAI

Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages

SCIENTIFIC REPORTS

IF3.9

2017-08-25121

OAAI

The clinical impact of an EML4-ALK variant on survival following crizotinib treatment in patients with advanced ALK-rearranged non-small-cell lung cancer

ANNALS OF ONCOLOGY

IF65.4

2017-07-017

OAAI

Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer

晚期ALK重排非小细胞肺癌中EML4-ALK融合变异体对各种ALK抑制剂的差异蛋白稳定性和临床反应

ANNALS OF ONCOLOGY

IF65.4

2017-04-01176

OAAI

Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs

支持EML4-ALK驱动的癌症的分子机制及其对靶向药物的反应

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2016-01-1189

OAAI

Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation

INVESTIGATIONAL NEW DRUGS

IF2.7

2013-09-2633

PREAI

Hepatitis B virus X protein induces Src homology 2-containing protein tyrosine phosphatase, SHP2, expression through the NF-kB pathway in HBV-infected hepatocellular carcinomas

CANCER RESEARCH

IF16.6

2012-04-010

PRE

RDEA119 synergy the anti-tumor effect of sorafenib in renal cell carcinoma cells

CANCER RESEARCH

IF16.6

2011-04-010

PRE

HISTONE DEACETYLASE INHIBITOR POTENTIATES SORAFENIB-INDUCED CELL DEATH IN RENAL CELL CARCINOMA CELL LINES

JOURNAL OF UROLOGY

IF6.8

2011-04-010

PREAI